Amplifying endogenous neuroprotective mechanisms is a promising avenue for stroke therapy. One target is mammalian target of rapamycin (mTOR), a serine/threonine kinase regulating cell proliferation, cell survival, protein synthesis, and autophagy. Animal studies investigating the effect of rapamycin on mTOR inhibition following cerebral ischemia have shown conflicting results.
Aim
To conduct a systematic review and meta-analysis evaluating the effectiveness of rapamycin in reducing infarct volume in animal models of ischemic stroke.
Summary of review
Our search identified 328 publications. Seventeen publications met inclusion criteria (52 comparisons: 30 reported infarct size and 22 reported neurobehavioral score). Study quality was modest (median 4 of 9) with no evidence of publication bias. The point estimate for the effect of rapamycin was a 21.6% (95% CI, 7.6%–35.7% p < 0.01) improvement in infarct volume and 30.5% (95% CI 17.2%–43.8%, p < 0.0001) improvement in neuroscores. Effect sizes were greatest in studies using lower doses of rapamycin.
Conclusion
Low-dose rapamycin treatment may be an effective therapeutic option for stroke. Modest study quality means there is a potential risk of bias. We recommend further high-quality preclinical studies on rapamycin in stroke before progressing to clinical trials.
PapadakisMHadleyGXilouriMet al.Tsc1 (hamartin) confers neuroprotection against ischemia by inducing autophagy. Nat Med2013; 19: 351–357.
2.
WangCYuJTMiaoDet al.Targeting the mTOR signaling network for Alzheimer's disease therapy. Mol Neurobiol2014; 49: 120–135.
3.
DeYoungMPHorakPSoferAet al.Hypoxia regulates TSC1/2-mTOR signaling and tumor suppression through REDD1-mediated 14-3-3 shuttling. Genes Dev2008; 22: 239–251.
4.
HardieDG. The AMP-activated protein kinase pathway – new players upstream and downstream. J Cell Sci2004; 117: 5479–5487.
5.
SaundersRNMetcalfeMSNicholsonML. Rapamycin in transplantation: a review of the evidence. Kidney Int2001; 59: 3–16.
6.
McKeageKMurdochDGoaKL. The sirolimus-eluting stent: a review of its use in the treatment of coronary artery disease. Am J Cardiovasc Drugs2003; 3: 211–230.
7.
JerndalMForsbergKSenaESet al.A systematic review and meta-analysis of erythropoietin in experimental stroke. J Cereb Blood Flow Metab2010; 30: 961–968.
8.
MacleodMRvan der WorpHBSenaESet al.Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke2008; 39: 2824–2829.
9.
de VriesRBMHHooijmansCRLangendamMWet al.A protocol format for the preparation, registration and publication of systematic reviews of animal intervention studies. Evid Base Preclin Med2015; 1: 1–9.
10.
MacleodMRO'CollinsTHowellsDWet al.Pooling of animal experimental data reveals influence of study design and publication bias. Stroke2004; 35: 1203–1208.
11.
BochelenDRudinMSauterA. Calcineurin inhibitors FK506 and SDZ ASM 981 alleviate the outcome of focal cerebral ischemic/reperfusion injury. J Pharmacol Exp Ther1999; 288: 653–659.
12.
BuckleyKMHessDLSazonovaIYet al.Rapamycin up-regulation of autophagy reduces infarct size and improves outcomes in both permanent MCAL, and embolic MCAO, murine models of stroke. Exp Transl Stroke Med2014; 6: 8.
13.
ChauhanASharmaUJagannathanNRet al.Rapamycin protects against middle cerebral artery occlusion induced focal cerebral ischemia in rats. Behav Brain Res2011; 225: 603–609.
14.
ChiOZBarsoumSVega-CottoNMet al.Effects of rapamycin on cerebral oxygen supply and consumption during reperfusion after cerebral ischemia. Neuroscience2016; 316: 321–327.
15.
ChiOZMellenderSJBarsoumSet al.Effects of rapamycin pretreatment on blood-brain barrier disruption in cerebral ischemia-reperfusion. Neurosci Lett2016; 620: 132–136.
16.
GuoWFengGYMiaoYYet al.Rapamycin alleviates brain edema after focal cerebral ischemia reperfusion in rats. Immunopharm Immunot2014; 36: 211–223.
17.
LiDWangCYaoYet al.mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type. FASEB J2016; 30: 3388–3399.
18.
LiQZhangTWangJXet al.Rapamycin attenuates mitochondrial dysfunction via activation of mitophagy in experimental ischemic stroke. Biochem Bioph Res Co2014; 444: 182–188.
19.
QiHYSuFYWanSet al.The antiaging activity and cerebral protection of rapamycin at micro-doses. CNS Neurosci Ther2014; 20: 991–998.
20.
SharkeyJButcherSP. Immunophilins mediate the neuroprotective effects of Fk506 in focal cerebral-ischemia. Nature1994; 371: 336–339.
21.
ShengRZhangLSHanRet al.Autophagy activation is associated with neuroprotection in a rat model of focal cerebral ischemic preconditioning. Autophagy2010; 6: 482–494.
22.
SuJYZhangTTWangKWet al.Autophagy activation contributes to the neuroprotection of remote ischemic perconditioning against focal cerebral ischemia in rats. Neurochem Res2014; 39: 2068–2077.
23.
XieLSunFWangJet al.mTOR signaling inhibition modulates macrophage/microglia-mediated neuroinflammation and secondary injury via regulatory T cells after focal ischemia. J Immunol2014; 192: 6009–6019.
24.
XieRWangPChengMet al.Mammalian target of rapamycin cell signaling pathway contributes to the protective effects of ischemic postconditioning against stroke. Stroke2014; 45: 2769–2776.
25.
YanWJZhangHPBaiXGet al.Autophagy activation is involved in neuroprotection induced by hyperbaric oxygen preconditioning against focal cerebral ischemia in rats. Brain Res2011; 1402: 109–121.
26.
YangZZhongLNZhongSCet al.Hypoxia induces microglia autophagy and neural inflammation injury in focal cerebral ischemia model. Exp Mol Pathol2015; 98: 219–224.
27.
Yin LL, Ye SS, Chen Z, et al. Rapamycin preconditioning attenuates transient focal cerebral ischemia/reperfusion injury in mice. Int J Neurosci 2012; 122: 748–756.
28.
CarloniSAlbertiniMCGalluzziLet al.Increased autophagy reduces endoplasmic reticulum stress after neonatal hypoxia-ischemia: role of protein synthesis and autophagic pathways. Exp Neurol2014; 255: 103–112.
29.
CarloniSBuonocoreGBalduiniW. Protective role of autophagy in neonatal hypoxia-ischemia induced brain injury. Neurobiol Dis2008; 32: 329–339.
30.
CarloniSGirelliSScopaCet al.Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia. Autophagy2010; 6: 366–377.
31.
DongFYaoRYuHet al.Neuroprotection of Ro25-6981 against ischemia/reperfusion-induced brain injury via inhibition of autophagy. Cell Mol Neurobiol2017; 37: 743–752.
32.
YangXHeiCLiuPet al.Inhibition of mTOR pathway by rapamycin reduces brain damage in rats subjected to transient forebrain ischemia. Int J Biol Sci2015; 11: 1424–1435.
33.
MacleodMRO'CollinsTHorkyLLet al.Systematic review and metaanalysis of the efficacy of FK506 in experimental stroke. J Cerebr Blood F Met2005; 25: 713–721.
34.
CardenasMESanfridsonACutlerNSet al.Signal-transduction cascades as targets for therapeutic intervention by natural products. Trends Biotechnol1998; 16: 427–433.
35.
LiJYFuruichiYMatsuokaNet al.Tacrolimus (FK506) attenuates biphasic cytochrome c release and Bad phosphorylation following transient cerebral ischemia in mice. Neuroscience2006; 142: 789–797.
36.
IshiiTAsaiTOyamaDet al.Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506. FASEB J2013; 27: 1362–1370.
37.
WestGBBrownJH. The origin of allometric scaling laws in biology from genomes to ecosystems: towards a quantitative unifying theory of biological structure and organization. J Exp Biol2005; 208: 1575–1592.
38.
KnightRJKahanBD. The place of sirolimus in kidney transplantation: Can we reduce calcineurin inhibitor renal toxicity?. Kidney Int2006; 70: 994–999.
39.
BolandBKumarALeeSet al.Autophagy induction and autophagosome clearance in neurons: Relationship to autophagic pathology in Alzheimer's disease. J Neurosci2008; 28: 6926–6937.
40.
CherraSJDagdaRKChuCT. Review: Autophagy and neurodegeneration: survival at a cost?. Neuropathol Appl Neurobiol2010; 36: 125–132.
Arriola ApeloSINeumanJCBaarELet al.Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell2016; 15: 28–38.
44.
Arriola ApeloSILammingDW. Rapamycin: an InhibiTOR of aging emerges from the soil of Easter Island. J Gerontol A Biol Sci Med Sci2016; 71: 841–849.
45.
LiHGaoAFengDet al.Evaluation of the protective potential of brain microvascular endothelial cell autophagy on blood-brain barrier integrity during experimental cerebral ischemia-reperfusion injury. Transl Stroke Res2014; 5: 618–626.
46.
LinALZhengWHalloranJJet al.Chronic rapamycin restores brain vascular integrity and function through NO synthase activation and improves memory in symptomatic mice modeling Alzheimer's disease. J Cereb Blood Flow Metab2013; 33: 1412–1421.
47.
ShiZYDengJXFuSet al.Protective effect of autophagy in neural ischemia and hypoxia: Negative regulation of the Wnt/beta-catenin pathway. Int J Mol Med2017; 40: 1699–1708.
48.
RothwellPMWarlowCP. Timing of TIAs preceding stroke – time window for prevention is very short. Neurology2005; 64: 817–820.
49.
ThackerELWigginsKLRiceKMet al.Short-term and long-term risk of incident ischemic stroke after transient ischemic attack. Stroke2010; 41: 239–243.
50.
van de BeekDKremersWKKushwahaSSet al.No major neurologic complications with sirolimus use in heart transplant recipients. Mayo Clin Proc2009; 84: 330–332.
51.
van de BeekDKremersWDalyRCet al.Effect of neurologic complications on outcome after heart transplant. Arch Neurol2008; 65: 226–231.
52.
LloveraGHofmannKRothSet al.Results of a preclinical randomized controlled multicenter trial (pRCT): Anti-CD49d treatment for acute brain ischemia. Sci Transl Med2015; 7: 299ra121.
53.
MaysamiSWongRPradilloJMet al.A cross-laboratory preclinical study on the effectiveness of interleukin-1 receptor antagonist in stroke. J Cereb Blood Flow Metab2016; 36: 596–605.
54.
DirnaglUHakimAMacleodMet al.A concerted appeal for international cooperation in preclinical stroke research. Stroke2013; 44: 1754–1760.
55.
SenaESvan der WorpHBBathPMet al.Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol2010; 8: e1000344.
56.
Wang Q, Liao J, Hair K, et al. Estimating the statistical performance of different approaches to meta-analysis of data from animal studies in identifying the impact of aspects of study design. Biorxiv 2018. DOI: https://doi.org/10.1101/256776.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
